You browser is out of date and some functionality on this site may be not supported.
Please consider upgrading to the latest version of your browser for the best possible experience.
Kindly note that this website is not compatible with this browser. Some features may not work. Inconvenience regretted.
Labsystems Diagnostics Oy develops and manufactures high quality enzyme immunoassays (EIA, FEIA) and MIF assays, biochemical and LC-MS assays , molecular (MDx) and Point-of-Care (POC) tests. The products are marketed globally for clinical laboratory use, home use and doctors' offices.
Molecular diagnostic tests detect specific sequences in DNA or RNA that may or may not be associated with disease. These tests play a key role in infectious diseases, oncology, pharmacogenomics, genetic disease screening, human leukocyte antigen typing and coagulation. Following diagnosis, molecular testing can help guide appropriate therapy by identifying specific therapeutic targets. Trivitron offers a unique list of kits and assays for diagnosing and monitoring various diseases.
Enzyme-linked immunosorbent assay (ELISA) also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. It is used as a diagnostic tool in medicine and pathology, as well as a quality-control test across industries. EIA tests serve as a useful tool for determining serum antibody concentrations such as the HIV test since it can be performed to evaluate either the presence of antigen or the antibody in a sample.
Liquid chromatography-mass spectrometry (LC-MS) is a technique borrowed from analytical chemistry that amalgamates the proficiency of both the Liquid Chromatography (LC) and Mass Spectrometry (MS). It combines the physical separation capabilities of LC with the mass analysis capabilities of MS. These tests are the laboratory techniques for identification, quantization and mass analysis of materials. Currently, liquid chromatography-mass spectrometers (LC-MS) are increasingly being used in a wide range of fields, such as pharmaceuticals, environment, foods, and industrial materials.
To run a precise and successful newborn screening program, there is a need for certain instruments and reagents. Highest quality and exceptional performance standards are mandatory for such instruments. Labsystems offers neonatal screening instruments with proven, superior technologies to ensure the highest levels of performance for your laboratory.
After birth, it is essential for your baby to have certain health checks to detect conditions and abnormalities. Few babies are diagnosed with conditions, but they can be taken care and controlled effectively to only prove that the benefits of screening and early detection are significant. For example, Thyroid tests on newborns within the first five days will help in detecting neonatal hyperthyroidism.
In the current scenario, fully automated instruments in medical laboratories across the world use the immunoassay principle with an enzyme as the reporter label for routine measurements of innumerable analytes in patient samples. Designed to be very sensitive, this Enzyme Immunoassay (EIA) is used to detect the presence of a substance, usually an antigen, in a liquid sample or wet sample.
Enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. It is used as a diagnostic tool in medicine and pathology, as well as a quality-control test across industries. EIA tests serve as a useful tool for determining serum antibody concentrations such as the HIV test since it can be performed to evaluate either the presence of antigen or the antibody in a sample.